NCT01900795

An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction

A Phase 2a, Single-Center, Randomized, Double-Blind, Double- Dummy, Placebo- and Active-Controlled Analgesic Study of an Oral Dose of V117957 4.5 mg for the Treatment of Postsurgical Pain Due to Third Molar Extraction

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 114 (actual)
• Sponsor: Purdue Pharma LP · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to assess the analgesic properties of an oral dose of V117957 4.5 mg aqueous suspension in the third molar extraction model

Conditions

• Postsurgical Pain Due to Third Molar Extraction

Interventions

Type	Name	Description
DRUG	V117957	V117957 4.5 mg suspension taken orally after surgery.
DRUG	Ibuprofen	Ibuprofen 400 mg tablets taken orally after surgery.
DRUG	Placebo	Placebo taken orally after surgery.

Timeline

• Start date: 2013-07-01
• Primary completion: 2013-11-01
• Completion: 2013-11-01
• First posted: 2013-07-16
• Last updated: 2013-12-05

Locations

1 site across 1 country: United States